Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Total Liabilities
Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has total liabilities worth CN¥2.39 Billion CNY (≈ $349.46 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Tonghua Golden-Horse Pharmaceutical Indu's assets to evaluate the company's liquid asset resilience ratio.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Total Liabilities Trend (1994–2025)
This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Tonghua Golden-Horse Pharmaceutical Indu total assets.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
StoneCo Ltd
NASDAQ:STNE
|
USA | $50.44 Billion |
|
Margun Enerji Uretim Sanayi ve Ticaret AS
IS:MAGEN
|
Turkey | TL7.70 Billion |
|
Hyperliquid Strategies Inc Common Stock
NASDAQ:PURR
|
USA | $187.14 Million |
|
Schiehallion Fund Ltd
LSE:MNTN
|
UK | $4.09 Million |
|
AtriCure Inc
NASDAQ:ATRC
|
USA | $160.21 Million |
|
Imerys SA
PA:NK
|
France | €3.25 Billion |
|
Prestige Brand Holdings Inc
NYSE:PBH
|
USA | $1.66 Billion |
|
Energa S.A.
WAR:ENG
|
Poland | zł22.46 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Tonghua Golden-Horse Pharmaceutical Indu net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1994–2025)
The table below shows the annual total liabilities of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.17 Billion ≈ $317.00 Million |
-2.78% |
| 2024-12-31 | CN¥2.23 Billion ≈ $326.06 Million |
+1.23% |
| 2023-12-31 | CN¥2.20 Billion ≈ $322.09 Million |
-4.99% |
| 2022-12-31 | CN¥2.32 Billion ≈ $338.99 Million |
+0.66% |
| 2021-12-31 | CN¥2.30 Billion ≈ $336.78 Million |
-13.99% |
| 2020-12-31 | CN¥2.68 Billion ≈ $391.58 Million |
+31.69% |
| 2019-12-31 | CN¥2.03 Billion ≈ $297.35 Million |
+62.65% |
| 2018-12-31 | CN¥1.25 Billion ≈ $182.81 Million |
-4.51% |
| 2017-12-31 | CN¥1.31 Billion ≈ $191.45 Million |
+14.56% |
| 2016-12-31 | CN¥1.14 Billion ≈ $167.12 Million |
-40.18% |
| 2015-12-31 | CN¥1.91 Billion ≈ $279.39 Million |
+204.96% |
| 2014-12-31 | CN¥626.09 Million ≈ $91.62 Million |
+27.28% |
| 2013-12-31 | CN¥491.91 Million ≈ $71.98 Million |
+78.69% |
| 2012-12-31 | CN¥275.29 Million ≈ $40.28 Million |
+0.95% |
| 2011-12-31 | CN¥272.69 Million ≈ $39.90 Million |
-11.09% |
| 2010-12-31 | CN¥306.71 Million ≈ $44.88 Million |
+7.48% |
| 2009-12-31 | CN¥285.36 Million ≈ $41.76 Million |
+10.81% |
| 2008-12-31 | CN¥257.51 Million ≈ $37.68 Million |
-5.51% |
| 2007-12-31 | CN¥272.53 Million ≈ $39.88 Million |
-3.38% |
| 2006-12-31 | CN¥282.05 Million ≈ $41.27 Million |
-73.43% |
| 2005-12-31 | CN¥1.06 Billion ≈ $155.33 Million |
+0.67% |
| 2004-12-31 | CN¥1.05 Billion ≈ $154.30 Million |
-7.90% |
| 2003-12-31 | CN¥1.14 Billion ≈ $167.53 Million |
+10.08% |
| 2002-12-31 | CN¥1.04 Billion ≈ $152.18 Million |
+4.62% |
| 2001-12-31 | CN¥994.08 Million ≈ $145.47 Million |
-15.82% |
| 2000-12-31 | CN¥1.18 Billion ≈ $172.81 Million |
+312.65% |
| 1999-12-31 | CN¥286.19 Million ≈ $41.88 Million |
+22.30% |
| 1998-12-31 | CN¥234.01 Million ≈ $34.24 Million |
+33.40% |
| 1997-12-31 | CN¥175.42 Million ≈ $25.67 Million |
+8.43% |
| 1996-12-31 | CN¥161.79 Million ≈ $23.67 Million |
+48.05% |
| 1995-12-31 | CN¥109.28 Million ≈ $15.99 Million |
+77.17% |
| 1994-12-31 | CN¥61.68 Million ≈ $9.03 Million |
-- |
About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive m… Read more